Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The cardiac arrest study hamburg (CASH)

Circulation

Volumn 102, Issue 7, 2000, Pages 748-754

  Kuck, Karl Heinz ^a   Cappato, Riccardo ^a   Siebels, Jürgen ^a   Rüppel, Rudolf ^a  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

Author keywords

Antiarrhythmia agents; Cardioversion; Defibrillation; Heart arrest; Resuscitation

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METOPROLOL; NITRIC ACID DERIVATIVE; PROPAFENONE; WARFARIN;

ADULT; AGED; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; FOLLOW UP; HEART ARREST; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033840161     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.7.748     Document Type: Article

References (34)

1. Long-term survival after prehospital cardiac arrest: Analysis of outcome during an 8 year study
2. Prehospital ventricular defibrillation: Prognosis and follow-up course
3. Survival after resuscitation from out-of-hospital ventricular fibrillation
4. Long-term survival after out-of-hospital cardiac arrest
5. A comparison of 7 antiarrhythmic drugs in patients with ventricular tachyarrhythmias
6. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study)
7. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
8. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction
9. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings
10. Long-term outcome with the automatic implantable cardioverter-defibrillator
11. Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe heart disease
12. Survival after implantation of the cardioverter defibrillator
13. Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias
14. Predictors of first discharge and subsequent survivals in patients with automatic implantable cardioverter defibrillators
15. Usefulness of the automatic implantable cardioverter defibrillator in improving survival of patients with severely depressed left ventricular function associated with coronary artery disease
16. Time to first shock and clinical outcome in patients receiving an automatic implantable cardioverter defibrillator
17. Actuarial incidence and pattern of occurrence of shocks following implantation of the automatic implantable cardioverter defibrillator
18. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
19. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias
20. ICD versus drugs in cardiac arrest survivors: Preliminary results of the cardiac arrest study Hamburg
21. Clinical experience, complications and survival in 70 patients with the automatic implantable cardioverter/defibrillator
22. The automatic implantable cardioverter-defibrillator: Efficacy, complications, and device failures
23. The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias
24. Nonparametric estimation from incomplete observations
25. Regression models and life-tables
26. Implantable defibrillator therapy: Does it really prolong life? How can we prove it?
27. ICD therapy
28. AVID necessity
29. Standardized reporting of ICD patient outcome: The report of the North American Society of Pacing and Electrophysiology policy conference; February 9-10, 1993
30. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors
31. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery
32. Implantable transvenous cardioverter-defibrillators
33. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: An overview of results from randomized controlled trials